THE WOODLANDS, TEXAS, DEC. 20, 2024 — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today...
Author - David Miller
Depression Risk Lower With GLP-1 Receptor Agonists Versus DPP-4...
MONDAY, Feb. 24, 2025 -- For older adults with type 2 diabetes (T2D), use of glucagon-like...
Glaukos Submits New Drug Application to U.S. FDA for Epioxa
ALISO VIEJO, Calif.–(BUSINESS WIRE) December 23, 2024 — Glaukos Corporation (NYSE:...
Yogurt Intake-Colorectal Cancer Link Differs by Abundance of...
TUESDAY, Feb. 25, 2025 -- The association of long-term yogurt intake with colorectal cancer...
Increase in Mortality Associated With Menthol Cigarette Use
TUESDAY, Feb. 25, 2025 -- Menthol cigarettes are associated with increased mortality risk...
Chimerix Submits Dordaviprone New Drug Application for...
DURHAM, N.C., Dec. 30, 2024 (GLOBE NEWSWIRE) — Chimerix (NASDAQ: CMRX), a biopharmaceutical...
Probability of Cardiovascular Events Lower in Type 1 Diabetes...
TUESDAY, Feb. 25, 2025 -- Diabetes mellitus type 1 (DM1) is associated with lower probability of...
Daily Screen Time Tied to Higher Myopia Risk
TUESDAY, Feb. 25, 2025 -- The risk for myopia increases significantly with one to four hours of...
Corcept Submits New Drug Application for Relacorilant as a...
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Dec. 30, 2024– Corcept Therapeutics...
NRx Pharmaceuticals, Inc. Files Initial Section of U.S. New Drug...
WILMINGTON, Del., Dec. 30, 2024 /PRNewswire/ — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)...